Consumer News Are Major Insurers Trying To Lower Your Drug Costs

Trump forcing insurers to pass rebates to consumers won’t lower drug prices

President Trump’s recent speech about lowering drug price has been both lauded as long-overdue and derided as an overly-broad policy blueprint that lacks real action steps. Among the most absurd ideas ... Read More

Big Pharma’s Profits Hit Hard as Medicare Slashes 15 Drug Prices by 71%

The U.S. government has finished its second round of drug price negotiations, reaching major discounts on 15 widely used prescription drugs. Some prices will drop by as much as 85 percent. This is a ... Read More

How Trump’s Online Drugstore May Affect Your Drug Costs

President Trump and top health officials announced a deal with Pfizer to try to lower Medicaid prices, and a website to help consumers buy drugs directly from manufacturers. By Rebecca Robbins ... Read More

Direct-To-Consumer Sales Can Fulfill Trump’s Drug Pricing Promises

Forbes contributors publish independent expert analyses and insights. Sally Pipes is a scholar and think tank CEO who writes on health care. "The White House would be wise to push DTC programs as a ... Read More

Pfizer OKs deal to lower drug costs for Medicaid

The most-favored-nation policy demands companies reduce Medicaid prices, increase the costs of their drugs overseas, promise to match foreign prices for future drugs to what they cost in the U.S. and ... Read More

Pfizer agrees to lower drug costs, others may, too, president says

Albert Bourla, chairman and chief executive officer of the pharmaceutical company Pfizer. speaks in the Oval Office of the White House on Tuesday, with, from left, Secretary of Health and Human ... Read More

TrumpRx to Lower Cost of GLP-1s, but Experts Say Overall Savings Are Minimal

Share on Pinterest The TrumpRx prescription drug savings program is expected to be available by early 2026. Eli Lilly and Novo Nordisk have agreed to sell their weight-loss drugs, Wegovy and Zepbound, ... Read More

Major insurers scale back Medicare Advantage and Part D plans for 2026

CVS Health, Humana, and UnitedHealth Group have announced that they will pull back on Medicare Advantage and Part D prescription drug plans next year. These changes are a response to financial ... Read More

Direct-to-consumer drug pricing could compete with prescription insurance

A new study offers a glimpse at how direct-to-consumer pharmacy pricing could one day present stiff competition to the private prescription drug insurance model, researchers say. Subscribe to our ... Read More

How to lower your prescription drug costs

Prescription drug costs continue to burden Americans, with billions of dollars spent each year on such drugs, and nearly one in four patients reporting difficulty affording their medications. But ... Read More

States Can Lower Drug Costs Through Smart Regulation

Editor's Note: This article appears in Governing's Fall 2025 Magazine. You can subscribe here. This is one of two arguments for and against state regulation of drug sales. Read an opposing viewpoint ... Read More

Medicare enrollment 2026; costs rise, and you might have to find drug plan on your own

New Jersey seniors face higher Medicare prescription drug prices and fewer plan choices for 2026. Many insurers are cutting commissions for brokers, potentially leaving seniors with less help to ... Read More